COR Q4 2025 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q4 2025 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$83.7B+5.9% YoY

Gross Profit

$2.6B3.1% margin

Operating Income

$855M1.0% margin

Net Income

-$340M-0.4% margin

EPS (Diluted)

$-1.75

QoQ Revenue Growth

+3.8%

Cash Flow

Operating Cash Flow

$3.1B

Free Cash Flow

$2.9B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$76.6B

Total Liabilities

$74.8B

Stockholders' Equity

$1.5B

Cash & Equivalents

$4.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83.7B	$79.1B	+5.9%
Gross Profit	$2.6B	$2.2B	+20.4%
Operating Income	$855M	$673M	+27.0%
Net Income	-$340M	$3M	-10144.5%

Revenue Segments

Pharmaceutical Distribution

$74.3B89%

International Healthcare Solutions

$7.9B9%

Animal Health

$1.5B2%

Geographic Segments

U.S. Healthcare Solutions

$75.8B91%

International Healthcare Solutions

$7.9B9%